{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:52:18Z","timestamp":1793260338534,"version":"4.5.0"},"reference-count":167,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>After the metabolic syndrome and its components, thyroid disorders represent the most common endocrine disorders, with increasing prevalence in the last two decades. Thyroid dysfunctions are distinguished by hyperthyroidism, hypothyroidism, or inflammation (thyroiditis) of the thyroid gland, in addition to the presence of thyroid nodules that can be benign or malignant. Thyroid cancer is typically detected <jats:italic>via<\/jats:italic> an ultrasound (US)-guided fine-needle aspiration biopsy (FNAB) and cytological examination of the specimen. This approach has significant limitations due to the small sample size and inability to characterize follicular lesions adequately. Due to the rapid advancement of high-throughput molecular biology techniques, it is now possible to identify new biomarkers for thyroid neoplasms that can supplement traditional imaging modalities in postoperative surveillance and aid in the preoperative cytology examination of indeterminate or follicular lesions. Here, we review current knowledge regarding biomarkers that have been reliable in detecting thyroid neoplasms, making them valuable tools for assessing the efficacy of surgical procedures or adjunctive treatment after surgery. We are particularly interested in providing an up-to-date and systematic review of emerging biomarkers, such as mRNA and non-coding RNAs, that can potentially detect thyroid neoplasms in clinical settings. We discuss evidence for miRNA, lncRNA and circRNA dysregulation in several thyroid neoplasms and assess their potential for use as diagnostic and prognostic biomarkers.<\/jats:p>","DOI":"10.3389\/fendo.2023.1218320","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T18:57:33Z","timestamp":1689965853000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["New biomarkers: prospect for diagnosis and monitoring of thyroid disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Mirjana T.","family":"Macvanin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran M.","family":"Gluvic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozidarka L.","family":"Zaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magbubah","family":"Essack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma R.","family":"Isenovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"B1","first-page":"30","article-title":"Diagnosis and treatment of patients with thyroid cancer","volume":"8","author":"Nguyen","year":"2015","journal-title":"Am Health Drug Benefits"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0251-9","article-title":"The role of surgery in the current management of differentiated thyroid cancer","volume":"47","author":"Conzo","year":"2014","journal-title":"Endocrine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198409000-00005","article-title":"Poorly differentiated (\"Insular\") thyroid carcinoma. a reinterpretation of langhans' \"Wuchernde struma\"","volume":"8","author":"Carcangiu","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrc1836","article-title":"Pathogenetic mechanisms in thyroid follicular-cell neoplasia","volume":"6","author":"Kondo","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)11199-8","article-title":"Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis","volume":"360","author":"Brenner","year":"2002","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 who classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(74)92428-3","article-title":"Letter: hypersecretion of calcitonin in neoplastic conditions","volume":"1","author":"Milhaud","year":"1974","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/nejm197111112852004","article-title":"Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay","volume":"285","author":"Melvin","year":"1971","journal-title":"N Eng J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.901004","article-title":"Predictive biomarkers in thyroid cancer","volume":"12","author":"Macerola","year":"2022","journal-title":"Front Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4158\/ep161208.gl","article-title":"American Association of clinical endocrinologists, American college of endocrinology, and associazione Medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules\u20132016 update","volume":"22","author":"Gharib","year":"2016","journal-title":"Endocr Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12022-013-9238-y","article-title":"Is there a role for on-site evaluation of thyroid fine needle aspiration to reduce the nondiagnostic rate","volume":"24","author":"Simsek","year":"2013","journal-title":"Endocr Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0243","article-title":"A Large multicenter correlation study of thyroid nodule cytopathology and histopathology","volume":"21","author":"Wang","year":"2011","journal-title":"Thyroid"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-0057-1","article-title":"Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis","volume":"46","author":"Trimboli","year":"2014","journal-title":"Endocrine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2017.01.046","article-title":"ACR thyroid imaging, reporting and data system (Ti-rads): white paper of the ACR TI-RADS committee","volume":"14","author":"Tessler","year":"2017","journal-title":"J Am Coll Radiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.246025","article-title":"Update on the evaluation of thyroid nodules","volume":"62","author":"Bernet","year":"2021","journal-title":"J Nucl Med"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2009.11.012","article-title":"mRNA transcripts as molecular biomarkers in medicine and nutrition","volume":"21","author":"Sunde","year":"2010","journal-title":"J Nutr Biochem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6060(96)80041-9","article-title":"Detection of circulating thyroid cells in peripheral blood","volume":"120","author":"Ditkoff","year":"1996","journal-title":"Surgery"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.12.5346","article-title":"Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood","volume":"83","author":"Ringel","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011101)92:9<2273::aid-cncr1573>3.0.co;2-y","article-title":"Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study","volume":"92","author":"Bellantone","year":"2001","journal-title":"Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1353","article-title":"LncRNA hotair influences cell growth, migration, invasion, and apoptosis via the mir-20a-5p\/Hmga2 axis in breast cancer","volume":"7","author":"Zhao","year":"2018","journal-title":"Cancer Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cca.2008.01.007","article-title":"Thyroglobulin mRNA expression in peripheral blood lymphocytes of healthy subjects and patients with thyroid disease","volume":"390","author":"Amakawa","year":"2008","journal-title":"Clin Chim Acta"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000020674","article-title":"Renal expression of two 'Thyroid-specific' genes: thyrotropin receptor and thyroglobulin","volume":"8","author":"Sellitti","year":"2000","journal-title":"Exp Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1209","article-title":"Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR","volume":"82","author":"Bojunga","year":"2000","journal-title":"Br J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031341","article-title":"Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients","volume":"89","author":"Elisei","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1258\/000456303321016231","article-title":"Quantitative detection of peripheral thyroglobulin mRNA has limited clinical value in the follow-up of thyroid cancer patients","volume":"40","author":"Span","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1904","article-title":"Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy","volume":"85","author":"Takano","year":"2001","journal-title":"Br J Cancer"},{"key":"B27","article-title":"Molecular staging using qualitative rt-pcr analysis detecting thyreoglobulin mRNA in the peripheral blood of patients with differentiated thyroid cancer after therapy","volume":"25","author":"Karavitaki","year":"2005","journal-title":"Anticancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031967","article-title":"Detection of thyrotropin-receptor messenger ribonucleic acid (Mrna) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer","volume":"89","author":"Chinnappa","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8203","article-title":"Analysis of tg transcripts by real-time RT-PCR in the blood of thyroid cancer patients","volume":"87","author":"Savagner","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2088","article-title":"Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer","volume":"92","author":"Chia","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2015.06.063","article-title":"Diagnostic accuracy of circulating thyrotropin receptor messenger rna combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology","volume":"159","author":"Aliyev","year":"2016","journal-title":"Surgery"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4158\/EP14425.OR","article-title":"Circulating thyroid-stimulating hormone receptor messenger RNA as a marker of tumor aggressiveness in patients with papillary thyroid microcarcinoma","volume":"21","author":"Aliyev","year":"2015","journal-title":"Endocr Pract"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181f5ba51","article-title":"Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples","volume":"252","author":"Milas","year":"2010","journal-title":"Ann Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1793","article-title":"Thyrotropin Receptor\/Thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer","volume":"90","author":"Wagner","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13369","article-title":"Circulating thyroid cancer biomarkers: current limitations and future prospects","volume":"87","author":"Nixon","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-015-0024-4","article-title":"Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma","volume":"8","author":"Ausavarat","year":"2015","journal-title":"Thyroid Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/jci16234","article-title":"The tsh receptor reveals itself","volume":"110","author":"Davies","year":"2002","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.7.5838","article-title":"Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor","volume":"84","author":"Valyasevi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1470733","article-title":"Real-time PCR provides evidence for thyrotropin receptor mrna expression in orbital as well as in extraorbital tissues","volume":"147","author":"Agretti","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41419-018-0527-8","article-title":"Lincrna 1700020i14rik alleviates cell proliferation and fibrosis in diabetic nephropathy via mir-34a-5p\/Sirt1\/Hif-1\u03b1 signaling","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.117.029004","article-title":"Circular non-coding RNA Hipk3 mediates retinal vascular dysfunction in diabetes mellitus","volume":"136","author":"Shan","year":"2017","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1904044","DOI":"10.1002\/smll.201904044","article-title":"Circulating exosomal mir-20b-5p inhibition restores Wnt9b signaling and reverses diabetes-associated impaired wound healing","volume":"16","author":"Xiong","year":"2020","journal-title":"Small"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00961-12","article-title":"Non-coding RNAs binding to the nucleoid protein HU in escherichia coli","author":"Macvanin","year":"2012","journal-title":"J Bacteriol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00998-15","article-title":"A new non-coding RNA arranges bacterial chromosome organization","volume":"6","author":"Qian","year":"2015","journal-title":"mBio"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2009.04.001","article-title":"The long and the short of non-coding RNAs","volume":"21","author":"Brosnan","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00941","article-title":"The role of long non-coding RNAs in thyroid cancer","volume":"10","author":"Peng","year":"2020","journal-title":"Front Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","article-title":"Unique features of long non-coding RNAa biogenesis and function","volume":"17","author":"Quinn","year":"2016","journal-title":"Nat Rev Genet"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky095","article-title":"Splicing regulation by long non-coding RNAs","volume":"46","author":"Romero-Barrios","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long non-coding RNAs in cancer pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA hotair reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-019-0583-7","article-title":"Previously undescribed thyroid-specific MiRNA sequences in papillary thyroid carcinoma","volume":"64","author":"Barros-Filho","year":"2019","journal-title":"J Hum Genet"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-019-00254-4","article-title":"Mirna-21 promotes cell proliferation and invasion via Vhl\/Pi3k\/Akt in papillary thyroid carcinoma","volume":"32","author":"Zang","year":"2019","journal-title":"Hum Cell"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/407123","article-title":"MicroRNA role in thyroid cancer development","volume":"2011","author":"Marini","year":"2011","journal-title":"J Thyroid Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-007-0023-7","article-title":"Differential expression of MiRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues","volume":"18","author":"Tetzlaff","year":"2007","journal-title":"Endocr Pathol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/molecules19056080","article-title":"Issues and prospects of MicroRNA-based biomarkers in blood and other body fluids","volume":"19","author":"Chevillet","year":"2014","journal-title":"Molecules"},{"key":"B58","first-page":"74","article-title":"MicroRNA expression profiles in differentiated thyroid cancer, a review","volume":"6","author":"Li","year":"2013","journal-title":"Int J Clin Exp Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.157198","article-title":"Analysis of circulating MicroRNA: preanalytical and analytical challenges","volume":"57","author":"McDonald","year":"2011","journal-title":"Clin Chem"},{"key":"B60","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of MicroRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3059","article-title":"Circulating MicroRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma","volume":"97","author":"Yu","year":"2012","journal-title":"J Clin Endocr Metab"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28254","article-title":"MicroRNA-222 and microrna-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer","volume":"119","author":"Lee","year":"2013","journal-title":"Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1923","article-title":"Circulating MiRNA95 and MiRNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian population","volume":"99","author":"Cantara","year":"2014","journal-title":"J Clin Endocr Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509603102","article-title":"The role of MicroRNA genes in papillary thyroid carcinoma","volume":"102","author":"He","year":"2005","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1677\/erc.1.01209","article-title":"MicroRNA deregulation in human thyroid papillary carcinomas","volume":"13","author":"Pallante","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132403","article-title":"Circulating mir-25-3p and mir-451a may be potential biomarkers for the diagnosis of papillary thyroid carcinoma","volume":"10","author":"Li","year":"2015","journal-title":"PloS One"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1004","article-title":"MicroRNAs in thyroid cancer","volume":"96","author":"de la Chapelle","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2013.1879","article-title":"The mir-221\/222 cluster, mir-10b and mir-92a are highly up-regulated in metastatic minimally invasive follicular thyroid carcinoma","volume":"42","author":"Jikuzono","year":"2013","journal-title":"Int J Oncol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.794490","article-title":"Biomarker value of mir-221 and mir-222 as potential substrates in the differential diagnosis of papillary thyroid cancer based on data synthesis and bioinformatics approach","volume":"12","author":"Cai","year":"2021","journal-title":"Front Endocrinol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070970","article-title":"Prognostic role of mir-221 and mir-222 expression in cancer patients: a systematic review and meta-analysis","volume":"11","author":"Ravegnini","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11030418","article-title":"Papillary thyroid carcinoma tissue mir-146b, -21, -221, -222, -181b expression in relation with clinicopathological features","volume":"11","author":"Kondrotien\u0117","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030636","article-title":"Microrna-146b: a novel biomarker and therapeutic target for human papillary thyroid cancer","volume":"18","author":"Chou","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4604","article-title":"Mir-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting Cxcl12","volume":"35","author":"Dong","year":"2016","journal-title":"Oncol Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3485","article-title":"Expression and function of Cxcl12\/Cxcr4\/Cxcr7 in thyroid cancer","volume":"48","author":"Zhu","year":"2016","journal-title":"Int J Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab836","article-title":"Recurrence of papillary thyroid cancer: a systematic appraisal of risk factors","volume":"107","author":"Nieto","year":"2022","journal-title":"J Clin Endocr Metab"},{"key":"B76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ncrna.2020.01.001","article-title":"Microrna-486-5p and microrna-486-3p: multifaceted pleiotropic mediators in oncological and non-oncological conditions","volume":"5","author":"ElKhouly","year":"2020","journal-title":"Non-coding RNA Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1914470","article-title":"Circular rna Circ_0062389 modulates papillary thyroid carcinoma progression via the mir-1179\/High mobility group box 1 axis","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820962125","article-title":"LncRNA hotair influences the growth, migration, and invasion of papillary thyroid carcinoma via affection on the mir-488-5p\/Nup205 axis","volume":"19","author":"Xia","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11620","article-title":"Expression of LncRNA-hotair in the serum of patients with lymph node metastasis of papillary thyroid carcinoma and its impact","volume":"20","author":"Wu","year":"2020","journal-title":"Oncol Lett"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s312621","article-title":"Tnrc6c-As1 promotes thyroid cancer progression by up-regulating Lpar5 via mir-513c-5p","volume":"13","author":"Tong","year":"2021","journal-title":"Cancer Manag Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-17-3766","article-title":"Long non-coding RNA Ab074169 inhibits cell proliferation via modulation of khsrp-mediated Cdkn1a expression in papillary thyroid carcinoma","volume":"78","author":"Gou","year":"2018","journal-title":"Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s209138","article-title":"Long non-coding RNA Zfas1 promotes progression of papillary thyroid carcinoma by sponging mir-590-3p and up-regulating Hmga2 expression","volume":"12","author":"Tong","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2018.08.014","article-title":"The role of long non-coding RNA Afap1-As1 in human malignant tumors","volume":"214","author":"Ji","year":"2018","journal-title":"Pathol Res Pract"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmx047","article-title":"LncRNA Tug1 influences papillary thyroid cancer cell proliferation, migration and emt formation through targeting mir-145","volume":"49","author":"Lei","year":"2017","journal-title":"Acta Biochim Biophys Sin (Shaghai)"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-019-00242-8","article-title":"The LncRNA Unc5b-As1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines","volume":"32","author":"Wang","year":"2019","journal-title":"Hum Cell"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7043509","article-title":"Long non-coding RNA Loc100129940-n is up-regulated in papillary thyroid cancer and promotes the invasion and progression","volume":"2019","author":"Choy","year":"2019","journal-title":"Int J Endocrinol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2018_180219N125","article-title":"Long non-coding RNA Linc00313 modulates papillary thyroid cancer tumorigenesis via sponging mir-4429","volume":"65","author":"Wu","year":"2018","journal-title":"Neoplasma"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1159\/000494786","article-title":"Long non-coding RNA hoxa-As2 promotes papillary thyroid cancer progression by regulating mir-520c-3p\/S100a4 pathway","volume":"50","author":"Xia","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2019.1617567","article-title":"Long noncoding RNA Malat1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating mir-200a-3p\/Foxa1","volume":"20","author":"Gou","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6502","article-title":"Long non-coding RNA bancr regulates cancer stem cell markers in papillary thyroid cancer via the Raf\/Mek\/Erk signaling pathway","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol Rep"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8810","article-title":"Expression of bancr promotes papillary thyroid cancer by targeting thyroid stimulating hormone receptor","volume":"16","author":"Zheng","year":"2018","journal-title":"Oncol Lett"},{"key":"B92","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13046-019-1321-x","article-title":"Hsa_Circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the Notch3\/Gatad2a axis","volume":"38","author":"Yao","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.08.175","article-title":"CircRNA circ-itch suppresses papillary thyroid cancer progression through mir-22-3p\/Cbl\/\u03b2-Catenin pathway","volume":"504","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2018.1480888","article-title":"Emerging roles of CircRNA_Nek6 targeting mir-370-3p in the proliferation and invasion of thyroid cancer via wnt signaling pathway","volume":"19","author":"Chen","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"B95","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41419-019-1439-y","article-title":"Circular RNA Circbach2 plays a role in papillary thyroid carcinoma by sponging mir-139-5p and regulating Lmo4 expression","volume":"10","author":"Cai","year":"2019","journal-title":"Cell Death Dis"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.04.011","article-title":"The roles of the epithelial-mesenchymal transition marker Prrx1 and mir-146b-5p in papillary thyroid carcinoma progression","volume":"184","author":"Hardin","year":"2014","journal-title":"Am J Pathol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/thy.2011.0081","article-title":"Microrna signature in thyroid fine needle aspiration cytology applied to \"Atypia of undetermined significance\" cases","volume":"22","author":"Shen","year":"2012","journal-title":"Thyroid"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-11-2487","article-title":"A panel of four mirnas accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration","volume":"18","author":"Keutgen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B99","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1186\/s12885-015-1917-2","article-title":"The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management","volume":"15","author":"Panebianco","year":"2015","journal-title":"BMC Cancer"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26587","article-title":"Microrna expression profiling is a potential diagnostic tool for thyroid cancer","volume":"118","author":"Vriens","year":"2012","journal-title":"Cancer"},{"key":"B101","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.oraloncology.2014.10.006","article-title":"Differential expression levels of plasma-derived mir-146b and mir-155 in papillary thyroid cancer","volume":"51","author":"Lee","year":"2015","journal-title":"Oral Oncol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-015-9363-x","article-title":"In situ hybridization analysis of mir-146b-5p and mir-21 in thyroid nodules: diagnostic implications","volume":"26","author":"Guo","year":"2015","journal-title":"Endocr Pathol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1427042","article-title":"Differences in MiRNA and MRNA profile of papillary thyroid cancer variants","volume":"2016","author":"Stokowy","year":"2016","journal-title":"Int J Endocrinol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2276","article-title":"Irak1, a target of mir-146b, reduces cell aggressiveness of human papillary thyroid carcinoma","volume":"101","author":"Chou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1733-0","article-title":"Microrna signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma","volume":"18","author":"Yip","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0027","article-title":"Mir-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the Braf(V600e) mutation","volume":"20","author":"Chou","year":"2010","journal-title":"Thyroid"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.03.001","article-title":"Sdf-1alpha up-regulates interleukin-6 through Cxcr4, Pi3k\/Akt, erk, and nf-Kappab-Dependent pathway in microglia","volume":"613","author":"Lu","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170830111531","article-title":"Targeting Cxcl12\/Cxcr4 axis in tumor immunotherapy","volume":"26","author":"Zhou","year":"2019","journal-title":"Curr Med Chem"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0045","article-title":"Microrna profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with ret status and outcome","volume":"22","author":"Mian","year":"2012","journal-title":"Thyroid"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-017-2227-7","article-title":"Mir-375 and Yap1 expression profiling in medullary thyroid carcinoma and their correlation with clinical-pathological features and outcome","volume":"471","author":"Galuppini","year":"2017","journal-title":"Virchows Arch"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1530\/erc-17-0389","article-title":"Circulating mir-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients","volume":"25","author":"Romeo","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.647369","article-title":"Serum mir-375 for diagnostic and prognostic purposes in medullary thyroid carcinoma","volume":"12","author":"Censi","year":"2021","journal-title":"Front Endocrinol"},{"key":"B113","doi-asserted-by":"crossref","DOI":"10.3390\/jmp2020014","article-title":"Molecular tests for risk-stratifying cytologically indeterminate thyroid nodules: an overview of commercially available testing platforms in the united states","volume":"2","author":"Nishino","year":"2021","journal-title":"J Mol Pathol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/dc.24100","article-title":"Utility of microdissected cytology smears for molecular analysis of thyroid malignancy","volume":"47","author":"Kumar","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2019.11.003","article-title":"Development and analytical validation of an expanded mutation detection panel for next-generation sequencing of thyroid nodule aspirates","volume":"22","author":"Ablordeppey","year":"2020","journal-title":"J Mol Diagn"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22365","article-title":"Analytical and clinical validation of pairwise microrna expression analysis to identify medullary thyroid cancer in thyroid fine-needle aspiration samples","volume":"129","author":"Ciarletto","year":"2021","journal-title":"Cancer Cythopathol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2016-204089","article-title":"Multicentre validation of a microrna-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears","volume":"70","author":"Lithwick-Yanai","year":"2017","journal-title":"J Clin Pathol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0254","article-title":"Molecular classification of thyroid nodules with indeterminate cytology: development and validation of a highly sensitive and specific new MiRNA-based classifier test using fine-needle aspiration smear slides","volume":"28","author":"Santos","year":"2018","journal-title":"Thyroid"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000095","article-title":"Critical analysis of molecular tests in indeterminate thyroid nodules","volume":"62","author":"Danilovic","year":"2018","journal-title":"Arch Endocrinol Metab"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102925","article-title":"Epigenetic mechanisms of lncrnas binding to protein in carcinogenesis","volume":"12","author":"Shin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2015.06.015","article-title":"LncRNAs and MicroRNAs with a role in cancer development","volume":"1859","author":"Liz","year":"2016","journal-title":"Biochem Biophys Acta"},{"key":"B122","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.tcb.2017.11.008","article-title":"Long non-coding RNA in cancer: wiring signaling circuitry","volume":"28","author":"Lin","year":"2018","journal-title":"Trends Cell Biol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-16-0356","article-title":"LncRNA Hoxa11-as promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors Prc2, Lsd1, and Dnmt1","volume":"76","author":"Sun","year":"2016","journal-title":"Cancer Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.5483\/bmbrep.2012.45.11.227","article-title":"Long non-coding RNA involvement in cancer","volume":"45","author":"Maruyama","year":"2012","journal-title":"BMB Rep"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112025","article-title":"Long non-coding RNA Hnf1a-As1 upregulates Otx1 to enhance angiogenesis in colon cancer via the binding of transcription factor Pbx3","volume":"393","author":"Wu","year":"2020","journal-title":"Exp Cell Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.canlet.2016.03.022","article-title":"Long non-coding RNA Casc11 interacts with hnrnp-K and activates the Wnt\/\u03b2-catenin pathway to promote growth and metastasis in colorectal cancer","volume":"376","author":"Zhang","year":"2016","journal-title":"Cancer Lett"},{"key":"B127","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.gendis.2019.01.003","article-title":"Emerging roles of LncRNAs in the post-transcriptional regulation in cancer","volume":"6","author":"He","year":"2019","journal-title":"Genes Dis"},{"key":"B128","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biochi.2019.05.010","article-title":"Interactions among LncRNAs, MiRNAs and mRNA in colorectal cancer","volume":"163","author":"Tang","year":"2019","journal-title":"Biochimie"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103334","article-title":"CeRNA in cancer: possible functions and clinical implications","volume":"52","author":"Qi","year":"2015","journal-title":"J Med Genet"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7712","article-title":"Overexpression of novel long intergenic Non\u2212Coding RNA Linc02454 is associated with a poor prognosis in papillary thyroid cancer","volume":"44","author":"Tan","year":"2020","journal-title":"Oncol Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000022705","article-title":"Construction and analysis of an aberrant LncRNA-MiRNA-mRNA network associated with papillary thyroid cancer","volume":"99","author":"Jiang","year":"2020","journal-title":"Medicine"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12564","article-title":"Suppression of long non-coding RNA Tnrc6c-As1 protects against thyroid carcinoma through DNA demethylation of Stk4 via the hippo signalling pathway","volume":"52","author":"Yang","year":"2019","journal-title":"Cell Prolif"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1159\/000495151","article-title":"Long non-coding RNAs in thyroid cancer: implications for pathogenesis, diagnosis, and therapy","volume":"42","author":"Mahmoudian-Sani","year":"2019","journal-title":"Oncol Res Treat"},{"key":"B134","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-981-13-1426-1_6","article-title":"Circular RNAs act as MiRNA sponges","volume":"1087","author":"Panda","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s316292","article-title":"Expression profiles of circular RNAs in human papillary thyroid carcinoma based on RNA deep sequencing","volume":"14","author":"Lv","year":"2021","journal-title":"Onco Targets Ther"},{"key":"B136","article-title":"Flow cytometry of thyroid tumors. study of fresh tissue in 50 patients","volume":"23","author":"Suissa","year":"1994","journal-title":"Presse Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2567","article-title":"Detection and prognostic significance of circulating tumor cells in patients with metastatic thyroid cancer","volume":"101","author":"Xu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0289","article-title":"Circulating myeloid-derived suppressor cells predict differentiated thyroid cancer diagnosis and extent","volume":"26","author":"Angell","year":"2016","journal-title":"Thyroid"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-014-0739-z","article-title":"Interleukins as markers of inflammation in malignant and benign thyroid disease","volume":"63","author":"Provatopoulou","year":"2014","journal-title":"Inflammation Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/690103","article-title":"Current and emerging biomarkers of cell death in human disease","volume":"2014","author":"Li","year":"2014","journal-title":"BioMed Res Int"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27937","article-title":"Soluble fas ligand as a biomarker of disease recurrence in differentiated thyroid cancer","volume":"119","author":"Owonikoko","year":"2013","journal-title":"Cancer"},{"key":"B142","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13000-020-00931-1","article-title":"Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinoma","volume":"15","author":"Lu","year":"2020","journal-title":"Diagn Pathol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(04)00215-6","article-title":"Mechanism of activation of the raf-erk signaling pathway by oncogenic mutations of b-raf","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0123","article-title":"Mutational patterns and novel mutations of the braf gene in a Large cohort of Korean patients with papillary thyroid carcinoma","volume":"22","author":"Jung","year":"2012","journal-title":"Thyroid"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.5858\/2010-0664-rair.1","article-title":"Molecular diagnostics of thyroid tumors","volume":"135","author":"Nikiforov","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766","article-title":"Mutations of the braf gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"B148","article-title":"High prevalence of braf mutations in thyroid cancer: genetic evidence for constitutive activation of the Ret\/Ptc-Ras-Braf signaling pathway in papillary thyroid carcinoma","volume":"63","author":"Kimura","year":"2003","journal-title":"Cancer Res"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1072","article-title":"Circulating Brafv600e in the diagnosis and follow-up of differentiated papillary thyroid carcinoma","volume":"98","author":"Pupilli","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2015.08.003","article-title":"Detection of circulating Braf(V600e) in patients with papillary thyroid carcinoma","volume":"18","author":"Lubitz","year":"2016","journal-title":"J Mol Diagn"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0607","article-title":"Braf(V600e) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study","volume":"93","author":"Elisei","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2917","article-title":"Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants","volume":"101","author":"Shi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab286","article-title":"Braf V600e status sharply differentiates lymph node metastasis-associated mortality risk in papillary thyroid cancer","volume":"106","author":"Tao","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1159\/000490699","article-title":"Evaluation of the role of Brafv600e somatic mutation on papillary thyroid cancer disease persistence: a prospective study","volume":"7","author":"Damiani","year":"2018","journal-title":"Eur Thyroid J"},{"key":"B155","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.anl.2011.07.011","article-title":"Brafv600e mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma","volume":"39","author":"Ahn","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-0139-0","article-title":"Braf mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice","volume":"45","author":"Puxeddu","year":"2014","journal-title":"Endocrine"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2014.02.003","article-title":"The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression","volume":"96","author":"Salajegheh","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1677\/jme.1.01618","article-title":"A differential proteomic approach to identify proteins associated with thyroid cell transformation","volume":"34","author":"Paron","year":"2005","journal-title":"J Mol Endocrinol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3390\/biology9030053","article-title":"Molecular imaging of galectin-1 expression as a biomarker of papillary thyroid cancer by using peptide-functionalized imaging probes","volume":"9","author":"Fanfone","year":"2020","journal-title":"Biol (Basel)"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwy001","article-title":"Galectin-3 and cancer stemness","volume":"28","author":"Nangia-Makker","year":"2018","journal-title":"Glycobiology"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-010-0838-3","article-title":"Serum cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors","volume":"136","author":"I\u0161i\u0107","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1186\/1916-0216-42-16","article-title":"Serum biomarkers of papillary thyroid cancer","volume":"42","author":"Makki","year":"2013","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6719","article-title":"Combination of galectin-3, Ck19 and hbme-1 immunostaining improves the diagnosis of thyroid cancer","volume":"14","author":"Arcolia","year":"2017","journal-title":"Oncol Lett"},{"key":"B164","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/1742-6413.55894","article-title":"Differential expression of galectin-3, Ck19, Hbme1, and ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy","volume":"6","author":"Saleh","year":"2009","journal-title":"Cytojournal"},{"key":"B165","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12957-021-02258-7","article-title":"Hbme1 and Ck19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (Niftp) vs other follicular patterned thyroid lesions","volume":"19","author":"Sadiq","year":"2021","journal-title":"World J Surg Oncol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1385\/ep:16:1:063","article-title":"The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in graves' disease","volume":"16","author":"Erkili\u00e7","year":"2005","journal-title":"Endocr Pathol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0901","article-title":"Serum diiodotyrosine - a biomarker to differentiate destructive thyroiditis from graves' disease","volume":"186","author":"Fujita","year":"2022","journal-title":"Eur J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1218320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T18:57:47Z","timestamp":1689965867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1218320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":167,"alternative-id":["10.3389\/fendo.2023.1218320"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1218320","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"article-number":"1218320"}}